Skip to main content

Peer Review reports

From: Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

Original Submission
23 Oct 2018 Submitted Original manuscript
25 Oct 2018 Author responded Author comments - Author- A Maughan
Resubmission - Version 2
25 Oct 2018 Submitted Manuscript version 2
13 Feb 2019 Author responded Author comments - Author- A Maughan
2 Dec 2018 Reviewed Reviewer Report - Yanni Sun
30 Jan 2019 Reviewed Reviewer Report - Elisabetta Teti
Resubmission - Version 3
13 Feb 2019 Submitted Manuscript version 3
5 Mar 2019 Author responded Author comments - Author- A Maughan
25 Feb 2019 Reviewed Reviewer Report - Elisabetta Teti
Resubmission - Version 4
5 Mar 2019 Submitted Manuscript version 4
26 Mar 2019 Author responded Author comments - Author- A Maughan
Resubmission - Version 5
26 Mar 2019 Submitted Manuscript version 5
Publishing
11 Apr 2019 Editorially accepted
3 May 2019 Article published 10.1186/s12879-019-3974-7

You can find further information about peer review here.

Back to article page